Shenzhen Hepalink Pharmaceutical Group Co Ltd Sustainability Reports

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. specializes in the research, development, and production of heparin-based pharmaceutical products for various medical applications.

Sector: Health Care

Country: China

Exchange: Shenzhen Stock Exchange

ISIN: CNE100000P02

8 reports from 2020 to 2024

• Shenzhen Hepalink Pharmaceutical Group Co Ltd 2024 Annual Report
• Shenzhen Hepalink Pharmaceutical Group Co Ltd 2024 ESG Report
• Shenzhen Hepalink Pharmaceutical Group Co Ltd 2023 Annual Report
• Shenzhen Hepalink Pharmaceutical Group Co Ltd 2023 ESG Report
• Shenzhen Hepalink Pharmaceutical Group Co Ltd 2022 ESG Report